Skip to content
Annika Bansal – Lifestyle
Author:
XVIVO Perfusion AB
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation
April 22, 2026
Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO’s Heart Technology Presented at ISHLT in Toronto
April 22, 2026
←
Previous Page
1
2